Aug. 25 at 6:27 PM
$AMFN During my working years with
$LH and
$DGX, we deal with companies like
$BDX and
$DHR, which have a ton of patents.
I remember LabCorp one day when it was looking to buy a lab in Tustin, CA.
When I researched the lab, it did not have much volume.
What's interesting is it has a lot of patents. The big 2 labs usually buy the lab because they have the volume, because volume equals revenue.
So patents are important. AMFN is preparing for the future with revenues from the patents or exclusivity.
In the lab business, they usually pay 5x the revenue.
I know, it's less than the multiplier in other fields since it's 10 to 30 times more.
What we have here—commercialization of Texatron, a fusion engine soon to power up data centers—is unique. Rarity also has a multiplier.
Take a look, NFA. DYODD.😎
5737👀